Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma - PubMed (original) (raw)
Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma
Itaru Sonoda et al. Cancer Res. 2004.
Abstract
Low-density lipoprotein receptor-related protein 1B (LRP1B) is frequently deleted in tumors of various types, but its status and expression in esophageal squamous cell carcinomas (ESCs) have never been reported. In the course of a program to screen ESC cell lines for copy-number aberrations using array-based comparative genomic hybridization, we identified a homozygous deletion of LRP1B. Genomic PCR experiments revealed homozygous deletions of LRP1B in additional ESC cell lines (total, 6 of 43; 14.0%) and in primary esophageal tumors (30 of 70; 42.9%). Moreover, expression of LRP1B mRNA was frequently silenced in ESC lines without homozygous deletions (14 of 37; 37.8%). Using bisulfite-PCR analysis and sequencing, we found that LRP1B-nonexpressing cells without homozygous deletions were highly methylated at a CpG island of LRP1B, a sequence possessing promoter activity. Treatment with 5-aza-2'-deoxycytidine restored expression of LRP1B in those ESC lines. Histone acetylation status correlated directly with expression of LRP1B and inversely with the methylation status of the CpG island. Methylation of LRP1B was also detected in primary esophageal tumors. Restoration of LRP1B expression in ESC cells reduced colony formation. These results suggest that loss of LRP1B function in esophageal carcinogenesis most often occurs either by homozygous deletion or by transcriptional silencing through hypermethylation of its CpG island.
Similar articles
- Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K. Tanaka H, et al. Cancer Res. 1998 Aug 1;58(15):3429-34. Cancer Res. 1998. PMID: 9699676 - PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki KI, Amagasa T, Inazawa J. Suzuki E, et al. Oncogene. 2007 Dec 13;26(57):7921-32. doi: 10.1038/sj.onc.1210589. Epub 2007 Jun 18. Oncogene. 2007. PMID: 17599052 - Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J. Tanaka K, et al. Oncogene. 2007 Sep 27;26(44):6456-68. doi: 10.1038/sj.onc.1210459. Epub 2007 Apr 16. Oncogene. 2007. PMID: 17438526 - Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.
Toh Y, Egashira A, Yamamoto M. Toh Y, et al. Gen Thorac Cardiovasc Surg. 2013 May;61(5):262-9. doi: 10.1007/s11748-013-0235-3. Epub 2013 Mar 26. Gen Thorac Cardiovasc Surg. 2013. PMID: 23529258 Review. - [Role of epigenetics in the carcinogenesis of head and neck carcinomas - possible new targeted therapy?].
Weber A, Dietz A, Tischoff I, Tannapfel A. Weber A, et al. Laryngorhinootologie. 2007 Jan;86(1):9-13. doi: 10.1055/s-2006-944821. Laryngorhinootologie. 2007. PMID: 17226729 Review. German.
Cited by
- Examination of a Low-density Lipoprotein Receptor Relative with 11 Ligand-binding Repeats (LR11) as a Biomarker in Esophageal Cancer.
Uchida T, Nasu M, Hashimoto T, Tsurumaru M, Kajiyama Y. Uchida T, et al. Juntendo Iji Zasshi. 2022 Oct 4;68(5):513-520. doi: 10.14789/jmj.JMJ22-0008-OA. eCollection 2022. Juntendo Iji Zasshi. 2022. PMID: 39081586 Free PMC article. - Prognostic Implications of LRP1B and Its Relationship with the Tumor-Infiltrating Immune Cells in Gastric Cancer.
Wang R, Zhang G, Zhu X, Xu Y, Cao N, Li Z, Han C, Qin M, Shen Y, Dong J, Ma F, Zhao A. Wang R, et al. Cancers (Basel). 2023 Dec 8;15(24):5759. doi: 10.3390/cancers15245759. Cancers (Basel). 2023. PMID: 38136305 Free PMC article. - The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
Liu W, Cheng H, Huang Z, Li Y, Zhang Y, Yang Y, Jin T, Sun Y, Deng Z, Zhang Q, Lou F, Cao S, Wang H, Niu X. Liu W, et al. Mol Oncol. 2024 Apr;18(4):939-955. doi: 10.1002/1878-0261.13526. Epub 2023 Oct 4. Mol Oncol. 2024. PMID: 37727135 Free PMC article. - Suppression of tumorigenesis in LUAD by LRP1B through regulation of the IL-6-JAK-STAT3 pathway.
Ye C, Chong W, Liu Y, Zhu X, Ren H, Xu K, Xie X, Du F, Zhang Z, Wang M, Ma T, Shang L, Li L, Chen H. Ye C, et al. Am J Cancer Res. 2023 Jul 15;13(7):2886-2905. eCollection 2023. Am J Cancer Res. 2023. PMID: 37560001 Free PMC article. - Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations.
Ohshima K, Nagashima T, Fujiya K, Hatakeyama K, Watanabe Y, Morimoto K, Kamada F, Shimoda Y, Ohnami S, Naruoka A, Serizawa M, Ohnami S, Kenmotsu H, Shiomi A, Tsubosa Y, Bando E, Sugiura T, Sugino T, Terashima M, Uesaka K, Urakami K, Akiyama Y, Yamaguchi K. Ohshima K, et al. Cancer Res Commun. 2023 Apr 24;3(4):684-696. doi: 10.1158/2767-9764.CRC-22-0364. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37377752 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials